Dr. Charles R. Frye, MD

Dr. Frye practices at North Mississippi Medical Center-West Point in West Point, Mississippi, part of North Mississippi Health Services.

Dr. Frye's NPI, 1740331099, was assigned on January 15, 2007. Dr. Frye graduated from University of Mississippi School of Medicine in 2000. Dr. Frye holds Louisiana license 313185.

Dr. Frye's primary practice is North Mississippi Medical Center-West Point, at 150 Medical Center Drive, West Point, MS 39773 in Clay County. The practice phone is (662) 495-2300.

Dr. Frye's primary practice is North Mississippi Medical Center-West Point in West Point, Mississippi, part of North Mississippi Health Services. Dr. Frye is also affiliated with North Mississippi Medical Center-Tupelo. The medical group on file is Relias Healthcare. Dmand AI also links Dr. Frye to 4 more hospitals, 8 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frye practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Frye's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Frye's licenses on file in 2 states: Louisiana and Mississippi.

CMS data shows 1,786 Medicare services from Dr. Frye across 10 procedure codes in 2024, for 613 Medicare patients. Medicare paid $152,423 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 613 Medicare patients who saw Dr. Frye in 2024. The largest group is 75 to 84, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frye's median patient age at 73, with 59% women.

In 2024, Dr. Frye wrote 395 Medicare Part D claims for 164 patients. 84% of them were for generic drugs. CMS names the drug for 194 of them, across 10 drugs with 11 or more claims each, at $11,465 in total drug cost. In 2023, CMS named 187 claims across 11 drugs.

Dr. Frye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 60 general payments to Dr. Frye from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $257.

Dr. Frye graduated from University of Mississippi School of Medicine in 2000.